Bull vs Bear: GlaxoSmithKline

Investors' Chronicle - Podcast tekijän mukaan Investors' Chronicle

kokeile Podimo ilmaiseksi 30! päivän ajan

kokeile Podimo ilmaiseksi 30! päivän ajan

universumia joka on täynnä satoja podcasteja ja äänikirjoja, klikkaa tätä kokeillaksesi

 Sponsored

GlaxoSmithKline (GSK) is a company that divides opinion and therefore an ideal candidate for the IC's Bull vs Bear series. In this episode, Simon Gergel from the Merchants Trust argues the bull case against the ICs pharma specialist (and GSK sceptic), Megan Boxall. Hosted on Acast. See acast.com/privacy for more information.

Visit the podcast's native language site